title: Comments on the EASL practice guidelines for the management of chronic hepatitis B: controversies in interferon-based therapy.
authors.forename: Harry L A
authors.initials: HL
authors.lastname: Janssen
authors.forename: Erik H C J
authors.initials: EH
authors.lastname: Buster
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D004279:DNA, Viral / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic
chemical_list: D004279:DNA, Viral; D006513:Hepatitis B e Antigens; D007372:Interferons; D000410:Alanine Transaminase